Codexis Inc (CDXS)

4.31
0.01 0.23
NASDAQ : Health Care
Prev Close 4.30
Day Low/High 0.00 / 0.00
52 Wk Low/High 2.93 / 4.63
Avg Volume 174.60K
Exchange NASDAQ
Shares Outstanding 41.18M
Market Cap 175.43M
EPS -0.20
P/E Ratio 12.17
Div & Yield N.A. (N.A)

Latest News

Codexis Completes Obligations Under Research And Development Agreement With Leading Biopharmaceutical Company

Codexis Completes Obligations Under Research And Development Agreement With Leading Biopharmaceutical Company

Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements

Codexis Files Lawsuit Against EnzymeWorks And CEO Junhua

Codexis Files Lawsuit Against EnzymeWorks And CEO Junhua "Alex" Tao For Patent Infringement And Misappropriation Of Trade Secrets

Codexis, Inc. (Nasdaq: CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces the filing of a lawsuit against EnzymeWorks and its founder, Junhua "Alex" Tao, for willful...

Insider Trading Alert - CDXS, KN And CNBKA Traded By Insiders

Insider Trading Alert - CDXS, KN And CNBKA Traded By Insiders

Stocks with insider trader activity include CDXS, KN and CNBKA

Insider Trading Alert - WTS, CDXS And CHMI Traded By Insiders

Insider Trading Alert - WTS, CDXS And CHMI Traded By Insiders

Stocks with insider trader activity include WTS, CDXS and CHMI

Codexis Collaborates With Leading Biopharmaceutical Company To Apply CodeEvolver Protein Engineering In Therapeutics Development Program

Codexis Collaborates With Leading Biopharmaceutical Company To Apply CodeEvolver Protein Engineering In Therapeutics Development Program

First Significant Agreement for Development of Novel Enzyme for Biologics Drug Development

Trifecta Stocks Weekly Roundup

While we await an interest rate hike, we check out the effects of the earnings parade on our portfolio.